Newly identified enzyme treats deadly bacterial infections in mice

Jul 02, 2008

By the time antibiotics made their clinical debut 70 years ago, bacteria had long evolved strategies to shield themselves. For billions of years, bacteria hurled toxic molecules at each other in the struggle to prosper, and those that withstood the chemical onslaught marched on. Now, with an uptick in antibiotic-resistant bacteria reaching alarming proportions, Rockefeller University scientists have identified an enzyme produced in viruses (called bacteriophages) that could stop these one-celled powerhouses dead in their tracks.

In research published this month in The Journal of Infectious Diseases, scientists led by Vincent Fischetti, head of the Laboratory of Bacterial Pathogenesis and Immunology, reveal that the newly identified enzyme, Cpl-1, can successfully treat symptoms of bacterial meningitis in young mice infected with Streptococcus pneumoniae, a highly resistant and deadly strain of bacteria. At a time when antibiotics have continued to prove futile, these findings may provide a solution to one of the more serious public health problems to hit this century.

“We have reached another critical milestone,” says Fischetti, who previously showed that Cpl-1 prevents ear infections in mice. “To argue that these enzymes can be clinically effective, we had to prove that they not only kill antibiotic-resistant bacteria but also reverse their symptoms of disease. And that’s what we did.”

Working with colleagues from the Institute for Infectious Diseases in Bern, Switzerland, Fischetti found that young mice infected with S. pneumoniae and then treated 18 hours later, once symptoms began, survived the potentially deadly infection. Moreover, Cpl-1 destroyed all traces of the most resistant and virulent strains of S. pneumoniae. In a test tube, this eradication took seconds; in the animal, it took a mere four hours and without collateral damage, suggesting that in mice, Cpl-1 is both a selective and safe treatment for drug-resistant bacterial meningitis.

Unlike the guerrilla warfare tactics of antibiotics, which give bacteria time to assemble their resources and develop resistance, phage enzymes strike with blitzkrieg speed and surprise, preventing bacteria from organizing a coherent defense. Without an effective strategy to fight them, bacteria are faced with a war they may not be able to win.

“We have had nothing to control these invasive diseases,” says Fischetti. “This approach may finally give us something.”

Citation: The Journal of Infectious Diseases 197(11): 1519–1522 (June 1, 2008)

Source: Rockefeller University

Explore further: Ginseng can treat and prevent influenza and RSV, researcher finds

add to favorites email to friend print save as pdf

Related Stories

Research team implants human innate immune cells in mice

Mar 18, 2014

(Phys.org) —Overcoming a major limitation to the study of the origins and progress of human disease, Yale researchers report that they have transplanted human innate immune cells into mouse models, which ...

Garlic counteracts virulent bacteria

Feb 18, 2014

Garlic contains a substance that is particularly effective in encounters with even the hardiest bacterial strains. A young researcher at the University of Copenhagen will soon be defending his Ph.D. thesis on the positive ...

Clever chemistry improves a new class of antibiotics

Jan 17, 2014

(Phys.org) —A new class of molecules called acyldepsipeptides—ADEPs—may provide a new way to attack bacteria that have developed resistance to antibiotics. Researchers at Brown and MIT have discovered ...

'Nanosponge vaccine' fights MRSA toxins

Dec 01, 2013

Nanosponges that soak up a dangerous pore-forming toxin produced by MRSA (methicillin-resistant Staphylococcus aureus) could serve as a safe and effective vaccine against this toxin. This "nanosponge vaccin ...

The benefits of bacteria for gut health

Oct 18, 2013

Scientists from the Emory University School of Medicine in Atlanta, United States have shown that specific gut bacteria are beneficial for maintaining a healthy intestine in the fruit fly Drosophila and mice and also contri ...

Recommended for you

Two expats die of MERS in Saudi commercial hub

Apr 20, 2014

Two foreigners died of MERS in the Saudi city of Jeddah, the health ministry said Saturday, as fears rise over the spreading respiratory virus in the kingdom's commercial hub.

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

menkaur
not rated yet Jul 02, 2008
yeah... and then there will be enzyme resistance ... you've got to use the medications in a right way and to control it - meaning - no selling it in shops etc...

More news stories